awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q40441775-0A0F0D3D-AAAC-4946-8B74-54CFC0FAE532
Q40441775-0A0F0D3D-AAAC-4946-8B74-54CFC0FAE532
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40441775-0A0F0D3D-AAAC-4946-8B74-54CFC0FAE532
Effectiveness of pegaspargase, gemcitabine, and oxaliplatin (P-GEMOX) chemotherapy combined with radiotherapy in newly diagnosed, stage IE to IIE, nasal-type, extranodal natural killer/T-cell lymphoma.
P2860
Q40441775-0A0F0D3D-AAAC-4946-8B74-54CFC0FAE532
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40441775-0A0F0D3D-AAAC-4946-8B74-54CFC0FAE532
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c015c189d5937d5e17364347e705ca30b2903697
P2860
FDA drug approval summary: pegaspargase (oncaspar) for the first-line treatment of children with acute lymphoblastic leukemia (ALL).